Erasca, Inc. (ERAS)
17.61
-0.02
(-0.11%)
USD |
NASDAQ |
Aug 24, 16:00
17.61
0.00 (0.00%)
After-Hours: 19:17
Erasca 1 Year Total Returns (Daily) : 1.08K% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.08K% |
| August 20, 2026 | 1.07K% |
| August 19, 2026 | 1.09K% |
| August 18, 2026 | 1.08K% |
| August 17, 2026 | 1.01K% |
| August 14, 2026 | 1.07K% |
| August 13, 2026 | 1.00K% |
| August 12, 2026 | 1.09K% |
| August 11, 2026 | 1.14K% |
| August 10, 2026 | 1.19K% |
| August 07, 2026 | 1.16K% |
| August 06, 2026 | 1.18K% |
| August 05, 2026 | 1.14K% |
| August 04, 2026 | 1.21K% |
| August 03, 2026 | 1.18K% |
| July 31, 2026 | 1.18K% |
| July 30, 2026 | 1.11K% |
| July 29, 2026 | 1.04K% |
| July 28, 2026 | 968.2% |
| July 27, 2026 | 984.5% |
| July 24, 2026 | 1.02K% |
| July 23, 2026 | 1.03K% |
| July 22, 2026 | 1.06K% |
| July 21, 2026 | 1.19K% |
| July 20, 2026 | 1.15K% |
| Date | Value |
|---|---|
| July 17, 2026 | 1.19K% |
| July 16, 2026 | 1.22K% |
| July 15, 2026 | 1.41K% |
| July 14, 2026 | 1.24K% |
| July 13, 2026 | 1.13K% |
| July 10, 2026 | 1.12K% |
| July 09, 2026 | 1.15K% |
| July 08, 2026 | 1.19K% |
| July 07, 2026 | 1.19K% |
| July 06, 2026 | 1.21K% |
| July 02, 2026 | 1.17K% |
| July 01, 2026 | 1.22K% |
| June 30, 2026 | 1.34K% |
| June 29, 2026 | 1.30K% |
| June 26, 2026 | 1.17K% |
| June 25, 2026 | 983.3% |
| June 24, 2026 | 937.9% |
| June 23, 2026 | 984.2% |
| June 22, 2026 | 1.00K% |
| June 18, 2026 | 876.4% |
| June 17, 2026 | 924.2% |
| June 16, 2026 | 852.3% |
| June 15, 2026 | 875.0% |
| June 12, 2026 | 818.3% |
| June 11, 2026 | 821.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Revolution Medicines, Inc. | 474.2% |
| Tango Therapeutics, Inc. | 240.7% |
| Cogent Biosciences, Inc. | 212.1% |
| Apogee Therapeutics, Inc. | 270.7% |
| Arrowhead Pharmaceuticals, Inc. | 319.8% |